Brief: Mabion Adopts Strategy For 2025-2030

Mabion SA

23/04/2025 17:53

April 23 (Reuters) - Mabion SA MABP.WA:

ADOPTS 2025-2030 STRATEGY

ALSO UPDATES ESG STRATEGY FOR 2025-2027

UNDER STRATEGY FOR 2025-2030 CHANGES BUSINESS MODEL TO "PURE PLAY" CDMO

UNDER STRATEGY FOR 2025-2030 FINALIZES TRANSFORMATION TO BIOLOGICAL CDMO FINANCED FROM GENERATED CASHFLOW

GOAL FOR 2025 IS TO INCREASE SALES REVENUES COMPARED TO 2024, MAINLY DUE TO EXPECTED TRANSLATION OF DEVELOPED BUSINESS RELATIONSHIPS INTO CONTRACTS

IN FOLLOWING YEARS 2026–2028 ANNUAL REVENUE POTENTIAL IS ESTIMATED AT PLN 150–350 MILLION

UNDER STRATEGY FOR 2025-2030 LOWERS ASSUMED CAPEX FOR CONSTRUCTION OF MABION II AND SHORTENS ITS COMPLETION TIME

UNDER STRATEGY FOR 2025-2030 TO EXPAND OFFER BY COMMERCIAL DS PRODUCTION IN ACCORDANCE WITH FDA'S GUIDELINES FOR U.S. MARKET

AFTER COMPLETION OF FIRST STAGE OF MABION II, I.E. IN 2029, MANAGEMENT ESTIMATES THAT REVENUE POTENTIAL WILL INCREASE TO OVER PLN 500 MILLION PER YEAR

UNDER STRATEGY FOR 2025-2030 TO MAINTAIN REVENUE POTENTIAL AFTER LAUNCH OF FIRST MABION II MODULE AT 400-500 MILLION ZLOTYS FROM 2029

UNDER STRATEGY TOTAL NECESSARY INVESTMENT OUTLAYS WERE ESTIMATED AT PLN 10-15 MILLION IN 2025 AND PLN 250-300 MILLION IN PERIOD 2026-2028

MAINTENANCE COSTS FROM 2029 SHOULD AMOUNT TO 5-10% OF ESTIMATED SALES REVENUES

UNDER STRATEGY FOR 2025-2030  TO REACH  EBITDA MARGIN IN 2026-2028 AT 35%

Source text: ID:nEMLWCgXa

Further company coverage: MABP.WA

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))